Oncologic Inc.
Division of Aduro Biotech/Oncologic Inc.
www.oncologic.net
Latest From Oncologic Inc.
Deal Watch: Bristol, Janssen Keep The Heat High In Cancer Immunotherapy Deal-Making
Bristol signs a licensing deal around CytomX’s Probody technology platform and becomes the third firm to set up a combination trial with Incyte’s IDO1 inhibitor. Janssen licenses novel immunotherapy candidates for prostate cancer from Aduro; Oncothyreon and Celldex arrange a combo trial in breast and ovarian cancer.
Start-Up Previews (9/02)
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Cancer Therapeutics, feature Cyclis Pharmaceuticals Inc., Mojave Therapeutics Inc., OncoGeneX Technologies Inc. and Oncologic Inc. Plus these selected Start-Ups across Health Care: CardiacAssist Inc., PharMetrics Inc., Sleep Solutions Inc. and Xoft microTube Inc.
Oncologic Inc.
Oncologic Inc. hopes to circumvent the heterogeneity of solid tumors with a multi-step process. It will target two independent cellular cancer characteristics-the presence of an endocytosing receptor, and sensitivity to a chemotherapeutic agent; then erect a novel chemical platform throughout the tumor to hold radioactive isotopes in place to kill the entire tumor, not just individual cancer cells.
Company Information
- Industry
- Biotechnology
-
Pharmaceuticals
- Drug Delivery
- Radiopharmaceuticals, Contrast Agents
- Therapeutic Areas
- Cancer
- Alias(es)
- Ownership
- Private
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Aduro Biotech
- Senior Management
-
Stephen T Isaacs, Pres. & CEO
Winston Salser, Chmn. - Contact Info
-
Oncologic Inc.
Phone: (510) 222-3501
3065 Richmond Pkwy.
Ste. 117
Richmond, CA 94806
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Oncologic Inc.
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice